INTUITIVE SURGICAL INC Quarterly Report for Q3 Ended Sep 30, 2023

Summary

Intuitive Surgical Inc. (ISRG) reported robust financial performance for the nine months ended September 30, 2023, with total revenue reaching $5.20 billion, a 14% increase year-over-year. This growth was driven by strong performance in instruments and accessories (up 22%) and service revenue (up 13%), indicating increased utilization of their da Vinci surgical systems. While system revenue saw a slight decrease of 2%, this was offset by a higher proportion of placements under operating leases, which generate recurring revenue over time. The company demonstrated solid profitability with an operating income of $1.32 billion for the nine-month period, up 9% year-over-year. Net income attributable to Intuitive Surgical, Inc. increased by 19% to $1.19 billion. The company maintained a strong liquidity position, with cash, cash equivalents, and investments totaling $7.52 billion as of September 30, 2023. ISRG also continued its commitment to shareholder returns, repurchasing $350 million of its common stock during the nine-month period, while maintaining a significant remaining authorization for future repurchases.

Key Highlights

• 1Total revenue increased 14% to $5.20 billion for the first nine months of 2023.
• 2Instruments and accessories revenue grew 22% to $3.13 billion, indicating strong procedure adoption.
• 3Service revenue increased 13% to $863 million, driven by a growing installed base.
• 4Net income attributable to Intuitive Surgical, Inc. rose 19% to $1.19 billion for the nine-month period.
• 5Operating income reached $1.32 billion for the nine months, a 9% increase year-over-year.
• 6The company ended the period with $7.52 billion in cash, cash equivalents, and investments, demonstrating a strong liquidity position.
• 7The da Vinci system installed base grew 13% year-over-year to approximately 8,285 systems.

Frequently Asked Questions